In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


Addiction Reviews

Edited by Edited by George R. Uhl (National Institutes of Health, Baltimore, Maryland)
Addiction Reviews

Published: February 2012

Volume 1248

This installment of Addiction Reviews offers reviews in the field of addiction from a variety of vantage points, including neurobiological, historical, and phenomenological perspectives.
Learn More

This volume presents reviews that cover a range of topics in addiction science, with authorship from the United States and European Union. The likely inclusion of craving in DSMV criteria for addiction confers special timeliness on the paper from Stephen Tiffany and Jennifer Wray. We can now look back on addiction therapeutics in general and the clinically- and financially-successful anti-addiction medication buprenorphine in the review from Nancy Campbell and Anne Lovell. Marcus Munafò and colleagues provide an important emphasis of the ways in which socioeconomic status interacts with a common addiction, smoking. Ivy Carroll and colleagues provide an excellent update on the medicinal chemistry of new designer drugs that proves his uncanny ability to trace designed drugs from the streets back to the papers in which their syntheses and properties were described. The often under-appreciated role of ultrastructural information in defining circuits important for addiction is reviewed by longtime leaders in this field Marisela Morales and Virginia Pickel. The important continuing contributions of smoking comorbidities are reviewed by Tony George and colleagues, and a framework for mouse models for smoking cessation is discussed a review by Scott Hall, George Uhl, and colleagues.